流感B病毒的自然历史-关于治疗,耐药性和治疗选择的当前知识
Ghayyas Ud Din1,2, Kinza Hasham3, Muhammad Nabeel Amjad1,2
1CAS Key Laboratory of Molecular Virology & Immunology, Institutional Center for Shared Technologies and Facilities, Pathogen Discovery and Big Data Platform, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, No. 320 Yueyang Road, Shanghai 200031, China.
Current issues in molecular biology
|January 22, 2024
概括
B型流感病毒对全球的健康和经济造成负担. 它的快速演变需要新的疫苗和治疗方法来对抗广泛的疫情和抗病毒耐药性.
科学领域:
- 病毒学 病毒学
- 基因组学就是基因组学.
- 流行病学 流行病学
背景情况:
- 乙型流感病毒 (IBV) 造成全球健康和经济上的重大影响,每年有数十亿例病例和数百万例死亡.
- 流行病,如山口和维多利亚血统爆发,突出IBV的实质性社会负担.
- 快速的突变和复制率使IBV能够逃避免疫力并发展抗药性,导致反复爆发.
研究的目的:
- 审查B型流感病毒的进化基因组组织和生命周期.
- 提供当前抗IBV药物,治疗策略和新出现的抗药性模式的概述.
- 突出预防和治疗IBV感染的挑战和前景.
主要方法:
- 关于B型流感病毒的科学出版物的文献综述.
- 对基因组数据的分析,以了解进化模式.
- 综合关于抗病毒疗法和疫苗开发的信息.
主要成果:
- 由于IBV具有快速的适应性,因此需要不断更新疫苗接种策略.
- 现有的抗病毒治疗由于新出现的耐药性而面临挑战.
- 了解IBV的基因组和生命周期复杂性对于有效控制至关重要.
结论:
- 有效预防和治疗B型流感病毒需要对其进化和生物学进行持续研究.
- 开发新型疫苗和治疗方法至关重要,以应对IBV的持续威胁.
- 解决耐药性和免疫逃避是未来IBV控制工作的关键优先事项.
相关概念视频
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Lytic Cycle of Bacteriophages
70.7K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.7K
Vaccinations
44.5K
Overview
44.5K


